Hepatitis C status of heart transplant recipients

Clinical Transplantation

Volumn 12, Issue 1, 1998, Pages 5-10

  Fagiuoli, S ^a   Cooper, D K C ^b,c   Zuhdi, N ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NONE

Author keywords

Heart transplantation; Hepatitis

Indexed keywords

INTERFERON; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; DISEASE SEVERITY; FEMALE; HEART TRANSPLANTATION; HEPATITIS C; HUMAN; INCIDENCE; LIVER BIOPSY; LIVER FAILURE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART TRANSPLANTATION; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL; RNA-DIRECTED DNA POLYMERASE;

EID: 0031937781     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. HOSENPUD JD, NOVICK RJ, BREEN TJ, KECK B, DAILY OR. The Registry of the International Society for Heart and Lung Transplantation: 12th Official Report - 1995. J Heart Lung Transpl 1995: 14: 805.
2. CADRANEL JF, GRIPPON P, MATTEI MF, et al. Prevalence and causes of long-lasting hepatic dysfunction after heart transplantation: a series of 80 patients. Artif Organs 1988: 12: 234.
3. HUISMAN AM, SCHALM SW, SIMOONS ML, et al. Disturbed liver function in heart transplantation candidates, two case reports. Neth J Med 1989: 35: 33.
4. CADRANEL JF, GRIPPON P, LUNEL F, et al. Chronic liver dysfunction in heart transplant recipients with special reference to viral B, C, and non-A, non-B, non-C hepatitis. Transplantation 1991: 52: 645.
5. LUNEL F, CADRANEL JP, PERRIN M, et al. Anti-hepatitis C virus (HCV) antibodies in heart transplant recipients with post- transplantation chronic viral B and non-A, non-B hepatitis. Dig Dis Sci 1991: 36: 124.
6. GULBIS B, ADLER M, OOMS HA, et al. Liver function studies in heart transplant recipients treated with cyclosporine A. Clin Chem 1988: 34: 1772.
7. SHADE RR, GUGLELMI A, VAN THIEL DH, et al. Cholestasis in heart transplant recipients treated with cyclosporine. Transpl Proc 1983: 15: 2757.
8. PERINI GO, BONADIMAN MD, FRACCAROLI GP, et al. Azathioprine- related cholestatic jaundice in heart transplant recipients. J Heart Transpl 1990: 9: 577.
9. CADRANEL JE, ERLINGER S, DESRUENNE M, et al. Chronic administration of cyclosporin A induces a decrease in hepatic excretory function in man. Dig Dis Sci 1992: 37: 1473.
10. KLINTMALM GB, IWATZUKI S, STARZL TE. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 1981: 32: 488.
11. POCHOT JM, PIRSON Y. Cyclosporin-diltiazem interaction. Lancet 1986: 1: 979.
12. ABI-MANSUR P, ARDIACA MC, ALLAM C, SHAMMA'A M. Trimethoprim-sulfamethoxazole-induced cholestasis. Am J Gastroent 1981: 76: 356.
13. TANNER AR. Hepatic cholestasis induced by trimethoprim. Br Med J 1986: 293: 1072.
14. MADDREY WC. Isoniazid-induced liver disease. Semin Liver Dis 1981: 1: 129.
15. LAKE-BAKAAR G, SCHEUER PJ, SHERLOCK S. Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J 1987: 294: 419.
16. SCHOCHETMAN G, CHIN-YIH O, JONES WK. Polymerase chain reaction. J Infect Dis 1988: 158: 1154.
17. JAZZAR A, FAGIUOLI S, SISSON S, ZUHDI N, COOPER DKC. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Clin Transpl 1995: 9: 334.
18. COOPER DKC. Immediate postoperative care and maintenance immunosuppressive therapy. In: The Transplantation and Replacement of Thoracic Organs. COOPER DKC, NOVITZKY D. (eds). Dordrecht: Kluwer Academic, 1990. pp. 89-99.
19. JAZZAR A, COOPER DKC, MUCHMORE JS, et al. A successful regimen to reduce cytomegalovirus disease in heart transplant patients. Transplantology 1993: 4: 47.
20. SCHUCH DR, KELLY PB, INGRAM MT, et al. Hepatitis C - importance of screening the organ donor preoperatively. J Thorac Cardiovasc Surg 1992: 104: 1174.
21. PEREIRA BJG, MEFORD EL, KIRKMAN RL, LEVEY AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991: 325: 454.
22. VINCENTI F, WEBER P, Kuo G, et al. Hepatitis C virus in cadaver organ donors: prevalence and risk of transmission to transplant recipients. Transpl Proc 1991: 23: 2651.
23. HANAFUSA T, ICHIKAWA Y, KYO M, et al. Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C. Transpl Proc 1995: 27: 956.
24. STEMPEL CA, LAKE J, Kuo G, et al. Hepatitis C-its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993: 55: 273.
25. BOLETTS J, DELLADETSIMA J, PSIMENOU E, et al. Liver biopsy is essential in anti-HCV(+) renal transplant patients irrespective of liver function tests and serology for HCV. Transpl Proc 1995: 27: 945.
26. WACHS ME, AMEND WJ, ASCHER NL, et al. The risk of transmission of hepatitis B from HBsAg (-), HBcAb (+), HBIgM (-) organ donors. Transplantation 1995: 59: 230.
27. KUO G, CHOO QL, ALTER HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis. Science 1989: 244: 302.